The healthcare sector generates 30% of all data worldwide. However, 97% of the knowledge it contains remains unused and health-critical findings remain hidden.
Floy® unlocks the potential of every radiological image. This is how we transform unused data into timely therapy.
Floy® opportunistically assesses bone density in routine MRI and CT scans of the spine to identify patients at risk, enabling timely action to prevent fractures.
Floy® opportunistically assesses vascular calcifications of the heart in routine CT scans of the chest, which can indicate the presence of coronary artery disease.
More information
Floy® opportunistically assesses vascular calcifications in mammography, which can be an indication of an increased risk of cardiovascular diseases such as heart attack or stroke.
More information
Floy® opportunistically assesses potentially pathological changes in the brain that may indicate circulatory disorders or damage to small vessels and are associated with strokes and dementia.
Floy® opportunistically detects an aneurysm in routine T2-weighted MRIs of the brain. If left untreated, an intracranial aneurysm carries a high risk of life-threatening cerebral hemorrhage.
More information
Floy® opportunistically quantifies liver fat content in MRIs and CTs for early assessment of metabolic health risk factors.
